We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Biogen
BIIB
$30B
| $39.5M | 0.05% |
215,436
-30,244
| -12% | -$5.57M |
|
377
Albemarle
ALB
$13.9B
| $39.5M | 0.05% |
220,010
+51,572
| +31% | +$8.81M |
|
378
Fox Class B
FOX
$21.8B
| $39.4M | 0.05% |
742,242
+223,018
| +43% | +$12.9M |
|
379
Alphatec Holdings
ATEC
$1.46B
| $39.3M | 0.05% |
3,616,330
+439,512
| +14% | +$6.4M |
|
|
WCC
380
WESCO International
WCC
$16.7B
| $39.3M | 0.05% |
143,649
+142,911
| +19,365% | +$40.1M |
|
381
Zoom
ZM
$28.2B
| $39.2M | 0.05% |
487,193
-142,268
| -23% | -$11.9M |
|
382
Universal Health Services
UHS
$10.2B
| $38.8M | 0.05% |
216,984
-8,347
| -4% | -$1.71M |
|
383
Synchrony
SYF
$24.7B
| $38.8M | 0.05% |
570,897
-372,280
| -39% | -$27.1M |
|
384
Sysco
SYY
$40.8B
| $38.7M | 0.05% |
543,199
+104,224
| +24% | +$8.62M |
|
385
Franco-Nevada
FNV
$41.1B
| $38.3M | 0.04% |
154,637
+21,926
| +17% | +$5.42M |
|
386
Knife River
KNF
$4.15B
| $38.3M | 0.04% |
468,678
-2,338
| -0.5% | -$188K |
|
387
Air Products & Chemicals
APD
$65.7B
| $38.3M | 0.04% |
131,709
+32,875
| +33% | +$9.06M |
|
388
Meritage Homes
MTH
$4.58B
| $38.2M | 0.04% |
617,502
+32,472
| +6% | +$2.3M |
|
389
Novanta
NOVT
$5.08B
| $38.2M | 0.04% |
323,264
+33,303
| +11% | +$4.37M |
|
390
Darden Restaurants
DRI
$23.3B
| $37.6M | 0.04% |
191,520
+61,921
| +48% | +$12.7M |
|
391
Consolidated Edison
ED
$40.1B
| $37.4M | 0.04% |
330,725
-37,841
| -10% | -$4.1M |
|
392
Herc Holdings
HRI
$5.02B
| $37.3M | 0.04% |
374,836
+36,893
| +11% | +$5.26M |
|
393
Adaptive Biotechnologies
ADPT
$3.59B
| $37.3M | 0.04% |
+2,688,081
| New | +$42.8M |
|
394
Airbnb
ABNB
$89.9B
| $37M | 0.04% |
293,339
+28,190
| +11% | +$3.67M |
|
395
CGI
GIB
$15.1B
| $37M | 0.04% |
506,140
+29,803
| +6% | +$2.38M |
|
396
Scotiabank
BNS
$107B
| $36.8M | 0.04% |
530,226
+195,250
| +58% | +$14.3M |
|
397
Wabtec
WAB
$49.1B
| $36.8M | 0.04% |
147,088
-46,872
| -24% | -$11.3M |
|
398
IDEAYA Biosciences
IDYA
$3.42B
| $36.7M | 0.04% |
1,101,145
+403,220
| +58% | +$13.5M |
|
399
Aflac
AFL
$64.9B
| $36.5M | 0.04% |
332,961
-177,518
| -35% | -$19.7M |
|
400
United Parcel Service
UPS
$88.6B
| $36.4M | 0.04% |
370,374
+93,637
| +34% | +$10M |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.